Duncan Learmouth
Direktor/Vorstandsmitglied bei Burroughs Wellcome & Co. Ltd.
Profil
Duncan Learmouth is currently a Director at Burroughs Wellcome & Co. Ltd.
He previously worked as a Non-Executive Chairman at Unilever Consumer Care Ltd.
from 2012 to 2013.
He also worked as a Director at ViiV Healthcare Ltd.
and as a Senior VP-Developing Countries & Market Access at GSK Plc from 2013 to 2014.
Aktive Positionen von Duncan Learmouth
| Unternehmen | Position | Beginn |
|---|---|---|
| Burroughs Wellcome & Co. Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Duncan Learmouth
| Unternehmen | Position | Ende |
|---|---|---|
| UNILEVER CONSUMER CARE LIMITED | Vorsitzender | 30.10.2013 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Direktor/Vorstandsmitglied | - |
| GSK PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| UNILEVER CONSUMER CARE LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
| Burroughs Wellcome & Co. Ltd. |
